OSCR

Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axons.

Code ↔ Paper

7 matches between paragraphs of the paper and lines of its authors' code, computed by the harvester (lexical-v1). Click a colored paragraph or line to see its counterpart.

5 blocks of code here have a permanent identifier (oscr:b:…), listed with the matches below: citable for good, with a page of its own. Select a match and press Cite to copy it. What a block identifier is.

The 7 matches · 2 of them tie a paragraph to a whole file without given lines: weak matches, whose lines are not tinted
  1. [1] § Methods › In vivo evoked dopamine release › Fiber photometry signal processing ↔ preprocess_and_binning.m, lines 63 to 181 · score 0.88 · sliding window, camera triggers, fluorescence traces, binned, velocity, baseline · block oscr:b:7Z50ZER3X61F9-U · Report a mismatch
  2. [2] § Methods › Pipelines for proteome analysis and data visualization › Gene ontology ↔ analysis code.zip/phosphopeptidesGSMLi2vsGSvehpublication.Rmd, lines 36 to 111 · score 0.81 · clusterProfiler, Cellular Components, Biological Process, db, mm, Pathways · block oscr:b:DVRW9GXXKWNK0-J · Report a mismatch
  3. [3] § Methods › In vivo evoked dopamine release › Spontaneous dopamine transient selection ↔ triggered_analysis.m, the whole file · a weak match · score 0.80 · spontaneous transients, double threshold, low threshold, high threshold, onset, trace · block oscr:b:BYGRM33NXAW0E-K · Report a mismatch
  4. [4] § Methods › In vivo evoked dopamine release › Spontaneous dopamine transient selection ↔ snippets/transient_by_threshold.m, the whole file · a weak match · score 0.72 · double threshold, low threshold, high threshold, Spontaneous, transients, trace · block oscr:b:C4CVRDXJEXV7B-L · Report a mismatch
  5. [5] § Results › LRRK2 phosphorylates RAB3 isoforms in vivo ↔ analysis code.zip/phosphopeptidesGSMLi2vsGSvehpublication.Rmd, lines 36 to 111 · score 0.57 · biological processes, log2FC, pathway, GO, enrichment, enriched · block oscr:b:DVRW9GXXKWNK0-J · Report a mismatch
  6. [6] § Results › LRRK2 phosphorylates RAB3 isoforms in vivo ↔ analysis code.zip/volcanoPlots.Rmd, lines 17 to 78 · score 0.53 · log2FC, Rab3a, Volcano, GS, vehicle, MLi · block oscr:b:VCPCTBF886Z4G-I · Report a mismatch
  7. [7] § Results › Phosphorylation of RAB3A decreases its binding to the effector proteins RIM1 and RIM2 from mouse brain ↔ analysis code.zip/volcanoPlots.Rmd, lines 17 to 78 · score 0.52 · log2FC, Rab3a, volcano, MLi, phosphorylated, proteins · block oscr:b:VCPCTBF886Z4G-I · Report a mismatch

Paper

Loaded from Europe PMC by your browser; OSCR does not store it: doi.org · Europe PMC

The paper is loaded when this pane is shown.

The authors' code

R Markdown · 178 lines · 5.6 KB · CC-BY-4.0 · 2 matches

  1. ---
  2. title: "Phosphopeptides (GSMLI-2vsGSveh) GO Analysis"
  3. author: "Hannah Serio"
  4. date: "2025-06-09"
  5. output: html_document
  6. ---
  7. ```{r libraries, include=FALSE}
  8. library(clusterProfiler)
  9. library(org.Mm.eg.db)
  10. library(ggplot2)
  11. library(DOSE)
  12. library(readxl)
  13. library(openxlsx)
  14. library(dplyr)
  15. ```
  16. # GO Analysis - Synaptosome Phos Quant Phosphopeptides
  17. ```{r GO Analysis, warning=FALSE}
  18. excel_file <- "Anton-SPM-GSMLi2vsGSVeh-volcano-phosphopeptide-20250508 LP (3).xlsx" # table was provided by Parisiadou Lab
  19. gene_data <- read_excel(excel_file)
  20. # filter for p-value <= 0.05, |log2FC| > 0.58
  21. gene_data_filtered_abs <- gene_data %>%
  22. filter(logpvalue >= -log10(0.05), log2FC > 0.58 | log2FC < -0.58)
  23. # extract the genes of interest
  24. genesPeptideGroupsABS <- gene_data_filtered_abs$"...1"
  25. genesPeptideGroupsABS <- unique(genesPeptideGroupsABS)
  26. ```
  27. # Run GO analysis with dotplot visualization
  28. ```{r PhosphopeptidesGSMLI2, warning=FALSE, fig.width=9, fig.height=6, fig.path='R_plots_PhosphopeptidesGSMLI2publication/', dev=c('png', 'pdf')}
  29. # function to perform GO analysis and generate boxplot
  30. run_go_plot <- function(genes,
  31. ont = "BP",
  32. orgdb = org.Mm.eg.db,
  33. keytype = "SYMBOL",
  34. plot_title = "GO Analysis") {
  35. # run GO enrichment
  36. go_result <- enrichGO(gene = genes,
  37. OrgDb = orgdb,
  38. keyType = keytype,
  39. ont = ont,
  40. pAdjustMethod = "BH",
  41. pvalueCutoff = 0.05)
  42. # convert to data frame and calculate -log10(pvalue)
  43. go_df <- as.data.frame(go_result)
  44. go_df$logP <- -log10(go_df$pvalue)
  45. # function to generate a dotplot
  46. make_plot <- function(df, top_n, suffix) {
  47. df_top <- df %>% arrange(desc(logP)) %>% head(top_n)
  48. ggplot(df_top, aes(x = logP, y = reorder(Description, logP), size = Count, color = p.adjust)) +
  49. geom_point() +
  50. scale_color_gradient(low = "blue", high = "red") +
  51. labs(
  52. x = "-log10(p-value)",
  53. y = NULL,
  54. title = paste0(plot_title, " (Top ", top_n, ")")
  55. ) +
  56. theme_minimal()
  57. }
  58. # create plot with 15 top categories showing
  59. plot_top15 <- make_plot(go_df, 15, "Top 15")
  60. return(list(top15 = plot_top15))
  61. }
  62. ### PeptideGroups - BIOLOGICAL PROCESS
  63. dotplotPeptideGroupsbpABS <- run_go_plot(genes = genesPeptideGroupsABS,
  64. ont = "BP",
  65. plot_title = "GO Analysis (BP): Phosphopeptides GSMLI2 (|log2FC| > 0.58)")
  66. dotplotPeptideGroupsbpABS
  67. ### PeptideGroups - Cellular Component
  68. dotplotPeptideGroupsccABS <- run_go_plot(genes = genesPeptideGroupsABS,
  69. ont = "CC",
  70. plot_title = "GO Analysis (CC): Phosphopeptides GSMLI2 (|log2FC| > 0.58)")
  71. dotplotPeptideGroupsccABS
  72. ## KEGG Pathway Analysis
  73. # need to reformat gene list to be Entrez ID's for KEGG analysis
  74. entrezPeptideGroups <- bitr(genesPeptideGroupsABS, fromType = "SYMBOL", toType = "ENTREZID", OrgDb = org.Mm.eg.db)
  75. # extract only the Entrez ID column
  76. entrezPeptideGroups <- entrezPeptideGroups$ENTREZID
  77. # run clusterProfiler KEGG with dotplot visualization
  78. keggResultPeptideGroups <- enrichKEGG(gene = entrezPeptideGroups,
  79. organism = "mmu",
  80. pAdjustMethod = "BH",
  81. pvalueCutoff = 1)
  82. # extract results as a dataframe
  83. keggPeptideGroups <- as.data.frame(keggResultPeptideGroups)
  84. # convert p-value to -log10(p-value)
  85. keggPeptideGroups$logP <- -log10(keggPeptideGroups$pvalue)
  86. ```
  87. ```{r Saving Results, eval=FALSE}
  88. run_go_plot <- function(genes,
  89. ont = "BP",
  90. orgdb = org.Mm.eg.db,
  91. keytype = "SYMBOL") {
  92. # run GO enrichment
  93. go_result <- enrichGO(gene = genes,
  94. OrgDb = orgdb,
  95. keyType = keytype,
  96. ont = ont,
  97. pAdjustMethod = "BH",
  98. pvalueCutoff = 1) # keep all results
  99. # convert to data frame and calculate -log10(pvalue)
  100. go_df <- as.data.frame(go_result)
  101. go_df$logP <- -log10(go_df$pvalue)
  102. return(list(result = go_df))
  103. }
  104. # create workbook
  105. wb <- createWorkbook()
  106. # list of results
  107. go_results <- list(
  108. "PeptideGroups_BP" = run_go_plot(genesPeptideGroupsABS, ont = "BP"),
  109. "PeptideGroups_MF" = run_go_plot(genesPeptideGroupsABS, ont = "MF"),
  110. "PeptideGroups_CC" = run_go_plot(genesPeptideGroupsABS, ont = "CC"),
  111. "PeptideGroups_KEGG GSMLI2" = list(result = keggPeptideGroups)
  112. )
  113. # write results to excel sheet
  114. for (name in names(go_results)) {
  115. df <- go_results[[name]]$result
  116. addWorksheet(wb, name)
  117. writeData(wb, name, df)
  118. # Style: yellow fill for significant rows
  119. yellowStyle <- createStyle(bgFill = "#FFE599")
  120. # Style: black header row with white text (optional: bold)
  121. headerStyle <- createStyle(fontColour = "#000000", halign = "center", textDecoration = "bold")
  122. addStyle(wb, sheet = name, style = headerStyle, rows = 1, cols = 1:ncol(df), gridExpand = TRUE)
  123. # Highlight full rows where p.adjust < 0.05
  124. rows_to_highlight <- which(df$p.adjust < 0.05) + 1 # data starts at row 2
  125. if (length(rows_to_highlight) > 0) {
  126. conditionalFormatting(
  127. wb, sheet = name,
  128. cols = 1:ncol(df),
  129. rows = rows_to_highlight,
  130. rule = 'TRUE',
  131. type = "expression",
  132. style = yellowStyle
  133. )
  134. }
  135. setColWidths(wb, sheet = name, cols = 2, widths = "auto")
  136. }
  137. # save the workbook
  138. saveWorkbook(wb, "phosphopeptidesGSMLI2_Results.xlsx", overwrite = TRUE)
  139. ```

phosphopeptidesGSMLi2vsGSvehpublication.Rmd, under CC-BY-4.0 · at the source

Overview

Authors: Chuyu Chen1,2, Qianzi He2,3, Giulia Tombesi1,2, Eve Napier4, Matthew Jaconelli2,5, Oscar Andrés Moreno-Ramos2,6, Hannah Serio1, Yahaira Naaldijk7, Vanessa Promes1,2, Amanda Schneeweis2,6, Kaitlyn Quinn2,3, Christopher Nasios1,2, Elisa Greggio8,9, Yevgenia Kozorovitskiy3, Daniel Arango1, Amir R Khan4, Dario R Alessi2,5, Daniel A Dombeck2,3, Sabine Hilfiker7, Rajeshwar Awatramani2,6, Loukia Parisiadou1,2
  1. Department of Pharmacology, Northwestern University, Chicago, IL USA
  2. Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD USA
  3. Department of Neurobiology, Northwestern University, Evanston, IL USA
  4. School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland
  5. Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, UK
  6. Department of Neurology, Northwestern University, Chicago, IL USA
  7. Department of Anesthesiology, Rutgers, New Jersey Medical School, Newark, NJ USA
  8. Department of Biology, University of Padova, Padova, Italy
  9. Centro Studi per la Neurodegenerazione (CESNE), University of Padova, Padova, Italy
Journal: Nature communications, volume 17, issue 1, article 9165
Dates: received 20 February 2026; accepted 25 June 2026; published online 28 July 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1038/s41467-026-75194-3 · PMID 42660892 · PMCID PMC13522591 · OpenAlex W4413835653
Open access: gold, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: genetics / omics (modality), human (organism), mouse (organism), Parkinson's (population), cellular / molecular (subfield)
Methods: Spectral & time-frequency, Statistics, Smoothing, state filtering, decompositions, Preprocessing, Evoked potentials, fMRI & imaging, Single-unit activity, calcium imaging, Connectivity
Keywords: Parkinson's disease, Cellular neuroscience
MeSH: Axons*, Dopamine*, Dopaminergic Neurons*, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2*, Parkinson Disease*, Animals, Disease Models, Animal, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Pars Compacta, Phosphorylation, Proteomics, rab3 GTP-Binding Proteins, Synapses (* major topic)
Topic: Parkinson's Disease Mechanisms and Treatments (Clinical Neurology, Medicine), according to OpenAlex
Funding: Michael J. Fox Foundation for Parkinson's Research (Michael J. Fox Foundation) (ASAP- 020600, ASAP-000463); NINDS NIH HHS (R01 NS147081, R01 NS119690); NIA NIH HHS (R21 AG089563); U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH) (R21AG089563, R01NS119690); NIH HHS (S10 OD032270)
Citations: cited by 1 paper (Europe PMC); 99 references in the paper
Research resources: Feature plots were generated using R RRID:SCR_001905, ShinyCell package99 RRID:SCR_022756, RRID:SRC_020996

Abstract

Parkinson’s disease (PD) is defined pathologically by loss of dopamine-producing neurons in the substantia nigra pars compacta (SNc). Yet synaptic dysfunction emerges much earlier, making it essential to define the mechanisms that drive early nigrostriatal deregulation. In the SNc, molecularly distinct dopamine neuron subtypes show differential susceptibility to PD. Here, we used intersectional genetic mouse models to determine how the PD-linked kinase LRRK2 affects vulnerable dopamine subtypes. Immunofluorescence and proximity-labeling proteomics revealed enriched LRRK2 expression in vulnerable dopamine neuron subclusters. High-resolution imaging showed that pathogenic LRRK2 disrupts presynaptic release-site organization in vulnerable dopamine axons, leading to reduced spontaneous and evoked striatal dopamine release in vivo. Proteomic analyses further showed that mutant LRRK2 increases phosphorylation of RAB3 proteins, impairing their interaction with the active-zone effectors RIM1 and RIM2. Together, these findings highlight a subtype-specific, cell-autonomous mechanism by which pathogenic LRRK2 impairs PD-vulnerable nigrostriatal synapses and provide a framework for therapeutic strategies targeting early synaptic deficits in PD.

Reproduced under the paper's license (CC BY), from the paper cited above.

Repositories

Its files are read in the Code ↔ Paper reader above, with 7 matches between paragraphs and lines of code.

curtain.proteo.info

License: none: the authors keep all their rights
State: the link answers, verified on 27 September 2026
Evidence: the link answers
Software Heritage: not checked
Found in: the text, “Statistical analysis and data visualization”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 1 check, the latest on 27 September 2026: the link answers (HTTP 200)
  • 27 September 2026: the link answers (HTTP 200)
At the source: curtain.proteo.info/#/

Zenodo 19930567

License: CC-BY-4.0
State: the link answers, verified on 27 September 2026
Evidence: files inventoried
Size: 5 files
Software Heritage: not checked
Found in: “Code availability”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Tools: ggplot2 (2 files), tidyverse (2 files), clusterProfiler (1 file)
Availability: 1 check, the latest on 27 September 2026: the link answers (HTTP 200)
  • 27 September 2026: the link answers (HTTP 200)
2 files
At the source:

Zenodo 20244434

License: CC-BY-4.0
State: the link answers, verified on 27 September 2026
Evidence: files inventoried
Size: 1 file
Software Heritage: not checked
Found in: “Code availability”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 1 check, the latest on 27 September 2026: the link answers (HTTP 200)
  • 27 September 2026: the link answers (HTTP 200)
8 files
At the source:

DombeckLab/lrrk2_photometry_analysis

License: MIT
State: the link answers, verified on 27 September 2026
Evidence: files inventoried
Commit: d34558fdde4b6665bd631c8fe47b8a1ef18f6a73, 30 July 2026
Languages: MATLAB (7)
Size: 10 files, 7 scripts
Software Heritage: not archived
Found in: “Code availability”
Holds: README, license file
Not found: CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 1 check, the latest on 27 September 2026: the link answers
  • 27 September 2026: the link answers
9 files

Code availability

The codes generated in this study have been deposited on Zenodo, https://doi.org/10.5281/zenodo.19930567; https://doi.org/10.5281/zenodo.20244434, and GitHub, https://github.com/DombeckLab/lrrk2_photometry_analysis.

Reproduced under the paper's license (CC BY), from the paper cited above.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 4 repositories of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 16 scripts, each with its path and the digest of its content;
  • 7 matches between paragraphs of the paper and lines of the code (method lexical-v1);
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

Datasets cited

Other data links

Data availability

The mass spectrometry proteomics data generated in this study have been deposited in the ProteomeXchange Consortium via the PRIDE partner repository, with dataset identifiers PXD065003 (https://www.ebi.ac.uk/pride/archive/projects/PXD065003), PXD065006 (https://www.ebi.ac.uk/pride/archive/projects/PXD065006), and PXD0651255 (https://www.ebi.ac.uk/pride/archive/projects/PXD065125). The processed proteomics data generated in this study are provided in the Supplementary data 1-3, and Gene Ontology analysis results are provided in the Supplementary data 4-5. Imaging data with metadata files generated in this study have been deposited in the BioStudies/BioImage Archive, with data indentifiers S-BIAD2070 (https://www.ebi.ac.uk/biostudies/bioimages/studies/S-BIAD2070), S-BIAD2071 (https://www.ebi.ac.uk/biostudies/bioimages/studies/S-BIAD2071), S-BIAD2072 (https://www.ebi.ac.uk/biostudies/bioimages/studies/S-BIAD2072), and S-BIAD2074 (https://www.ebi.ac.uk/biostudies/bioimages/studies/S-BIAD2074). Raw tubular Data generated in this study from all experiments, and uncropped western blot images with metadata files in this study are available in source data file via the open-access option on the Zenodo repository (https://doi.org/10.5281/zenodo.19930567). The protocols used in this study were uploaded to protocols.io; their DOIs are listed in the Supplementary Table 1. Source data are provided with this paper.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 21 authors, 2 keywords, 18 MeSH terms, 5 funders, 97 references, 3 RRIDs.

Cite

This paper

Chen, C., He, Q., Tombesi, G., Napier, E., Jaconelli, M., Moreno-Ramos, O. A., Serio, H., Naaldijk, Y., Promes, V., Schneeweis, A., Quinn, K., Nasios, C., Greggio, E., Kozorovitskiy, Y., Arango, D., Khan, A. R., Alessi, D. R., Dombeck, D. A., Hilfiker, S., . . . Parisiadou, L. (2026). Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axons. Nature communications, 17(1), 9165. https://doi.org/10.1038/s41467-026-75194-3

BibTeX

@article{chen2026leucine,
author = {Chen, Chuyu and He, Qianzi and Tombesi, Giulia and Napier, Eve and Jaconelli, Matthew and Moreno-Ramos, Oscar Andrés and Serio, Hannah and Naaldijk, Yahaira and Promes, Vanessa and Schneeweis, Amanda and Quinn, Kaitlyn and Nasios, Christopher and Greggio, Elisa and Kozorovitskiy, Yevgenia and Arango, Daniel and Khan, Amir R and Alessi, Dario R and Dombeck, Daniel A and Hilfiker, Sabine and Awatramani, Rajeshwar and Parisiadou, Loukia},
title = {{Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axons}},
journal = {Nature communications},
year = {2026},
month = jul,
volume = {17},
number = {1},
pages = {9165},
publisher = {Nature Portfolio},
issn = {2041-1723},
doi = {10.1038/s41467-026-75194-3},
url = {https://doi.org/10.1038/s41467-026-75194-3},
pmid = {42660892},
pmcid = {PMC13522591}
}

RIS

TY - JOUR
AU - Chen, Chuyu
AU - He, Qianzi
AU - Tombesi, Giulia
AU - Napier, Eve
AU - Jaconelli, Matthew
AU - Moreno-Ramos, Oscar Andrés
AU - Serio, Hannah
AU - Naaldijk, Yahaira
AU - Promes, Vanessa
AU - Schneeweis, Amanda
AU - Quinn, Kaitlyn
AU - Nasios, Christopher
AU - Greggio, Elisa
AU - Kozorovitskiy, Yevgenia
AU - Arango, Daniel
AU - Khan, Amir R
AU - Alessi, Dario R
AU - Dombeck, Daniel A
AU - Hilfiker, Sabine
AU - Awatramani, Rajeshwar
AU - Parisiadou, Loukia
TI - Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axons
T2 - Nature communications
J2 - Nat Commun
PY - 2026
DA - 2026/07/28
VL - 17
IS - 1
SP - 9165
SN - 2041-1723
PB - Nature Portfolio
DO - 10.1038/s41467-026-75194-3
UR - https://doi.org/10.1038/s41467-026-75194-3
LA - en
ER -

CSL-JSON

{
"id": "10.1038/s41467-026-75194-3",
"type": "article-journal",
"title": "Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axons",
"container-title": "Nature communications",
"author": [
{
"family": "Chen",
"given": "Chuyu"
},
{
"family": "He",
"given": "Qianzi"
},
{
"family": "Tombesi",
"given": "Giulia"
},
{
"family": "Napier",
"given": "Eve"
},
{
"family": "Jaconelli",
"given": "Matthew"
},
{
"family": "Moreno-Ramos",
"given": "Oscar Andrés"
},
{
"family": "Serio",
"given": "Hannah"
},
{
"family": "Naaldijk",
"given": "Yahaira"
},
{
"family": "Promes",
"given": "Vanessa"
},
{
"family": "Schneeweis",
"given": "Amanda"
},
{
"family": "Quinn",
"given": "Kaitlyn"
},
{
"family": "Nasios",
"given": "Christopher"
},
{
"family": "Greggio",
"given": "Elisa"
},
{
"family": "Kozorovitskiy",
"given": "Yevgenia"
},
{
"family": "Arango",
"given": "Daniel"
},
{
"family": "Khan",
"given": "Amir R"
},
{
"family": "Alessi",
"given": "Dario R"
},
{
"family": "Dombeck",
"given": "Daniel A"
},
{
"family": "Hilfiker",
"given": "Sabine"
},
{
"family": "Awatramani",
"given": "Rajeshwar"
},
{
"family": "Parisiadou",
"given": "Loukia"
}
],
"container-title-short": "Nat Commun",
"volume": "17",
"issue": "1",
"page": "9165",
"DOI": "10.1038/s41467-026-75194-3",
"PMID": "42660892",
"PMCID": "PMC13522591",
"ISSN": "2041-1723",
"publisher": "Nature Portfolio",
"URL": "https://doi.org/10.1038/s41467-026-75194-3",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
28
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.7554/elife.101035 [code]
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2&lt;sup&gt;G2019S&lt;/sup&gt; model of Parkinson's disease.
Journal: eLife
In common: clusterProfiler, ggplot2, tidyverse, Parkinson's, genetics / omics, mouse, 1 other category, 23 references, 4 authors
[2] doi:10.1038/s41380-025-03030-z [code]
LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons.
Journal: Molecular psychiatry
In common: tidyverse, Parkinson's, mouse, cellular / molecular, 18 references, 5 authors
[3] doi:10.1038/s42003-022-04136-8 [code]
R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations.
Journal: Communications biology
In common: Parkinson's, mouse, cellular / molecular, 16 references, author Loukia Parisiadou
[4] doi:10.1073/pnas.2613593123 [code]
Calbindin stratifies midbrain dopaminergic neurons governing distinct aspects of locomotion.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: ggplot2, tidyverse, Parkinson's, mouse, 17 references, author Rajeshwar Awatramani
[5] doi:10.1038/s41593-023-01401-9 [code]
Unique functional responses differentially map onto genetic subtypes of dopamine neurons.
Journal: Nature neuroscience
In common: ggplot2, tidyverse, Statistics and Machine Learning Toolbox, 10 references, 2 authors
[6] doi:10.7554/elife.67900
Pathogenic LRRK2 control of primary cilia and Hedgehog signaling in neurons and astrocytes of mouse brain.
Journal: eLife
In common: Parkinson's, mouse, cellular / molecular, 9 references, author Dario R Alessi
[7] doi:10.1016/j.nbd.2026.107379 [code]
DYRK1A and Parkinson's disease, facts and hypotheses.
Journal: Neurobiology of disease
In common: ggplot2, tidyverse, Parkinson's, cellular / molecular, 10 references
[8] doi:10.7554/elife.89482 [code]
Transcriptomic atlas of midbrain dopamine neurons uncovers differential vulnerability in a Parkinsonism lesion model.
Journal: eLife
In common: ggplot2, tidyverse, NCBI GEO GSE178265, Parkinson's, genetics / omics, mouse, 7 references
[9] doi:10.1038/s41593-022-01061-1 [code]
Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson's disease.
Journal: Nature neuroscience
In common: ggplot2, tidyverse, NCBI GEO GSE178265, Parkinson's, genetics / omics, cellular / molecular, 6 references
[10] doi:10.1073/pnas.2412029122 [code]
Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: Parkinson's, mouse, cellular / molecular, 6 references, author Dario R Alessi

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.1038/s41467-026-75194-3.svg)](https://openscicode.org/badge/doi/10.1038/s41467-026-75194-3)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.1038/s41467-026-75194-3.svg
   :target: https://openscicode.org/badge/doi/10.1038/s41467-026-75194-3
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1038/s41467-026-75194-3"><img src="https://openscicode.org/badge/doi/10.1038/s41467-026-75194-3.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

On GitHub, open the README, choose Edit (the pencil), paste the snippet under the title, then "Commit changes".

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.